pentobarbital will reduce the level or effect of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid coadministration of bedaquiline with potent CYP3A4 inducers as a result of potential for lowered therapeutic effectpentobarbital will lessen the level or impact of celecoxib by influencing hepat